[PDF] Top 20 REPOSITORIO INSTITUCIONAL DA UFOP: Short-term therapy with simvastatin reduces inflammatory mediators and heart inflammation during the acute phase of experimental Chagas disease.
Has 10000 "REPOSITORIO INSTITUCIONAL DA UFOP: Short-term therapy with simvastatin reduces inflammatory mediators and heart inflammation during the acute phase of experimental Chagas disease." found on our website. Below are the top 20 most common "REPOSITORIO INSTITUCIONAL DA UFOP: Short-term therapy with simvastatin reduces inflammatory mediators and heart inflammation during the acute phase of experimental Chagas disease.".
REPOSITORIO INSTITUCIONAL DA UFOP: Short-term therapy with simvastatin reduces inflammatory mediators and heart inflammation during the acute phase of experimental Chagas disease.
... ability of the host to control the infection may dictate the balance that exists between the inflamma- tory disease course and the typical regulatory immune ... See full document
9
REPOSITORIO INSTITUCIONAL DA UFOP: Weak Values and the quantum phase space.
... upon the measuring system, implementing a small translation of the initial wave function in the position basis, but which can be measured from the mean value of the ... See full document
7
REPOSITORIO INSTITUCIONAL DA UFOP: Lipoprotein(a) as a risk factor associated with ischemic heart disease : Ouro Preto Study.
... to the World Health Organization criteria [17]. Waist and hip circumference were measured and classified according to Han et ...[19] with abnormal values ...men and >0.80 in women. ... See full document
6
REPOSITORIO INSTITUCIONAL DA UFOP: Avaliação da terapia de combinação do Itraconazol e Benznidazol no tratamento da doença de Chagas experimental.
... SCHIJMAN A.G., BISIO M., ORELLANA L., SUED M., DUFFY T., MEJIA JARAMILLO A.M., CURA C., AUTER F., VERON V., QVARNSTROM Y., DEBORGGRAEVE S., HIJAR G., ZULANTAY I., LUCERO R.H., VELAZQUEZ E., TELLEZ T., SANCHEZ L.Z., ... See full document
91
REPOSITORIO INSTITUCIONAL DA UFOP: Efficacy of Lychnopholide polymeric nanocapsules after oral and intravenous administration in murine experimental Chagas disease.
... for the etiological treatment of CD, namely, benznidazole (BZ) (LAFEPE and Abarax/Elea) and nifurtimox (NFX) (Lampit/ ...effective during the recent acute and ... See full document
8
REPOSITORIO INSTITUCIONAL DA UFOP: Experimental benznidazole treatment of Trypanosoma cruzi II strains isolated from children of the Jequitinhonha Valley, Minas Gerais, Brazil, with Chagas disease.
... treated with BZ during the TAP of infection showed a signifi- cant reduction in the parameters related to parasitaemia (area under the curve of parasitaemia, PP and ... See full document
9
REPOSITORIO INSTITUCIONAL DA UFOP: Follow-up of experimental chronic Chagas’ disease in dogs : use of polymerase chain reaction (PCR) compared with parasitological and serological methods.
... of the infection has been reproduced with relative facility by different authors, especially in young animals (Andrade, 1984; Pedreira de Castro and Brener, 1985; Lana et ...However, ... See full document
11
REPOSITORIO INSTITUCIONAL DA UFOP: Development of chronic cardiomyopathy in canine Chagas disease correlates with high IFN-g, TNF-a, and low IL-10 production during the acute infection phase.
... micro-camera and the KS300 software built into the Kontron Elektronick/Carl Zeiss image ...analyzer. The inflammatory process was evaluated by a correlation index between the number ... See full document
10
REPOSITORIO INSTITUCIONAL DA UFOP: What is the role of inflammatory mediators on energy metabolism?
... Furthermore, with in vivo effect, a study showed that IL-15 chronic administration (seven days) resulted in a BAT reduction of 33% in healthy ...by the lipogenesis inhibition, through lipoprotein ... See full document
8
REPOSITORIO INSTITUCIONAL DA UFOP: Highly diluted medication reduces parasitemia and improves experimental infection evolution by Trypanosoma cruzi.
... model, the evolution of the disease is irreversible, culminating in the death of the animals, an increase in the survival period is an indi- cator of a good ... See full document
9
Short-term therapy with simvastatin reduces inflammatory mediators and heart inflammation during the acute phase of experimental Chagas disease
... Statin and treatment scheme - A previous set of ex- periments was performed to determine the toxicity of simvastatin (Sanval, SP, Brazil) treatment in mice (n = 8/ group) using a daily ... See full document
9
TO STUDY THE RELATIONSHIP OF SERUM HIGH SENSITIVE C REACTIVE PROTEIN AND ITS SHORT TERM PROGNOSTIC SIGNIFICANCE IN ACUTE ISCHEMIC STROKE
... J of Evolution of Med and Dent Sci/ eISSN- 2278-4802, pISSN- 2278-4748/ ...those with C-reactive protein <10.1 mg/L. These finding were consistent with our study and showed ... See full document
4
Cytokine profiling in Chagas disease: towards understanding the association with infecting Trypanosoma cruzi discrete typing units (a BENEFIT TRIAL sub-study).
... for the activation of the antigen-specific immune responses and iii) detection of infection by non-hematopoietic cells, which are the principal targets of the ... See full document
8
Cell therapy in experimental model of inflammatory bowel disease
... as the Table 1 ...treated with stem cells versus control animals (Table ...to the severe injury caused by the administration of the alcoholic solution of TNBS, thereby ... See full document
8
Trypanosoma cruzi: Immunoglobulin isotype profiles during the acute phase of canine experimental infection with metacyclic or blood trypomastigotes
... infected with MT and BT forms of T. cruzi, and demonstrated that the pre-patent period was 23 days in the MT group and 19 days in the BT group, findings that are in ... See full document
6
Braz. J. Cardiovasc. Surg. vol.29 número1
... people, and other 20 million are at risk of acquiring the disease ...that the disease is no longer conined to South America due to international ...fact, Chagas ... See full document
3
Evolução Clínica Pós-Implante de Desfibrilador Cardíaco: Pacientes Chagásicos Versus Isquêmicos.
... perceptions of the public health care ...comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular ...arrhythmias. ... See full document
7
J. Bras. Nefrol. vol.37 número1
... summary, the factors that contribute to AKI- associated mortality vary with time and differ in the early and ...modify the risk of early mortality occurring in less than ... See full document
6
Clinics vol.69 número5
... trial. The inclusion criteria were as follows: hospitalization for decompensated heart failure, defined by worsening of symptoms until fatigue or dyspnea at rest; low cardiac output, defined by ... See full document
6
THE AUTHORS’ REPLY THE TREATMENT OF CHAGAS DISEASE PATIENTS WITH NITRODERIVATIVE IS UNSATISFACTORY
... complying with full treatment prescribed by physicians; 2) lack of clinical findings showing a benefit of treatment with nitroderivatives; 3) lymphoproliferative tumors, such as those ... See full document
7
temas relacionados